YFRM Technologies, Inc. Completes Acquisition of the Integrative Stem Cell Institute
May 21 2013 - 7:30AM
Marketwired
YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm) is pleased to
announce the completion of its acquisition of the Integrative Stem
Cell Institute (the ISCI). The new company, to be called "the
Integrative Stem Cell Institute," will continue the pioneering work
of the ISCI in the field of cell-based regenerative medicine. The
ISCI will be housed in Cancun's Hospital Galenia and will combine a
world-class medical facility with a state-of-the-art laboratory in
the investigational treatments of patients with chronic and
degenerative diseases as part of controlled clinical studies.
The new company will provide point-of-care therapies based upon
cell-based, regenerative medicine. The company will focus on the
treatment of patients with limited or no options, and who suffer
from diseases for which current medicine provides little or no
alleviation. The ISCI combines a state-of-the-art, ISO 7 laboratory
with cell-based treatments and nutritional, occupational, physical
and hyperbaric oxygen therapies to provide a unique and highly
integrative medical approach.
Juan Castillo, MD, founder of the ISCI, said, "Combining these
two companies has allowed the ISCI to advance quickly into a global
leadership position in this emerging field. Regenerative medicine
is the future of patient care." Dr. Castillo continued, "Physicians
from around the world have used stem cells to treat thousands of
patients with diseases such as MS, Parkinson's and autism. Our
methods, combined with an interdisciplinary team of physicians,
provide a new benchmark for quality patient care."
YaFarm has requested shares of its stock be issued to members of
the ISCI management, which will give them controlling interest, and
made arrangements for delivery of books and records. As a result of
the transaction, Brian Hermenze and Cody McDowell have resigned
from the Board and as President and Chief Executive Officer. Dr.
Juan Casteel, Elizabeth Casteel, and David Kugelman have been
appointed to the Board of Directors.
About Integrative Stem Cell Institute
(ISCI) The Integrative Stem Cell Institute (ISCI) is a premier
provider of point-of-care, stem cell-based therapies for patients
from around the world. With a state of the art laboratory housed
within the Hospital Galenia in Cancun, Mexico, the ISCI combines
the most advanced scientific application of stem cells with second
to none medical care within the structure of adaptive clinical
trials to effectively track long term outcomes and assure patient
safety.
More information on The Integrative Stem Cell Institute is
available on the company's website at www.iscelli.com.
SAFE HARBOR STATEMENT
This press release may contain certain forward-looking
statements and information, as defined within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934, and is subject to the Safe Harbor
created by those sections. Forward-looking statements are
inherently subject to risks and uncertainties, some of which cannot
be predicted or quantified. This material contains statements about
expected future events and/or financial results that are
forward-looking in nature and subject to risks and uncertainties.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward looking
statements are subject include, but are not limited to, the effect
of government regulation, competition, adequate financing, and
other material risks. Such forward-looking statements by definition
involve risks, uncertainties and other factors, which may cause the
actual results, performance, or achievements to be materially
different from the statements made herein.
Contact: The Integrative Stem Cell Institute Miranda Abrahams
Miranda@iscelli.com Investor Contact Atlanta Capital Partners, LLC
David Kugelman (866) 692-6847 info@atlcp.com
Profile Solutions (CE) (USOTC:PSIQ)
Historical Stock Chart
From Aug 2024 to Sep 2024
Profile Solutions (CE) (USOTC:PSIQ)
Historical Stock Chart
From Sep 2023 to Sep 2024